Stock, Johanna <br/><br/>
Prospective study on the potential of RAAS blockade to halt renal disease in Alport syndrome patients with heterozygous mutations.  [electronic resource] 

 -  Pediatric nephrology (Berlin, Germany)  01 2017 
 - 131-137 p.  digital 
<br/><br/> Publication Type: Journal Article; Observational Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1432-198X 
<br/><br/><label>Standard No.: </label>10.1007/s00467-016-3452-z  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Age of Onset<br/>Child<br/>Child, Preschool<br/>Disease Progression<br/>Female<br/>Follow-Up Studies<br/>Genotype<br/>Heterozygote<br/>Humans<br/>Infant<br/>Infant, Newborn<br/>Kaplan-Meier Estimate<br/>Kidney Failure, Chronic--prevention & control<br/>Male<br/>Middle Aged<br/>Mutation<br/>Nephritis, Hereditary--complications<br/>Prospective Studies<br/>Renal Insufficiency, Chronic--drug therapy<br/>Renin-Angiotensin System--drug effects<br/>Treatment Outcome<br/>Young Adult